Abstract Submission for BOPA Symposium 2021

Delegates are invited to present results of their clinical and technical work as a poster with some selected as an oral presentation. The author/s should submit via the BOPA website by noon on Friday 16th July 2021.

Abstracts will be reviewed and marked by the BOPA Audit and Research Sub-Committee, and chosen authors will be invited to display their poster for the duration of the conference, with the posters achieving high scores selected for oral presentation.

Selected abstracts will be published in a supplement to the Journal of Oncology Pharmacy Practice (JOPP), providing authors with a citation in a peer reviewed journal. The winning presentation will receive a prize worth £2,000 to attend an international conference or pay towards research funding including open access publishing fees.

DEADLINE: Friday 16th July 2021

For further information and to submit your abstract, please go to https://www.bopa.org.uk/abstractsubmission-2021/

Late Breaking Abstracts: Abstracts relating to the Covid-19 pandemic will be considered for presentation by the research committee if completed work is submitted after the 16th July deadline. Please contact the A&R committee ([email protected]) to request a late submission relating to Covid-19.

This year the Audit and Research committee will be providing 1:1 support via appointment, we have four slots available in April. Please contact BOPA A&R ([email protected]) if you are interested in receiving this support.

Best wishes,

BOPA Audit and Research Sub-Committee

Latest News

By BOPA E&T Subcommittee on 18th November 2025

BOPA Introduction to Cancer Course, Scotland, March 2026 – registration OPENS soon!

The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…

Read article
By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article